selected publications
- CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?. American journal of respiratory and critical care medicine. 2023 Editorial Article GET IT
-
Targeting fibrosis, mechanisms and cilinical trials.
Signal transduction and targeted therapy.
2022
Review
GET IT
Times cited: 32 -
Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.
iScience.
2022
Academic Article
GET IT
Times cited: 17082 -
Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
The American journal of pathology.
2022
Academic Article
GET IT
Times cited: 11 -
Lung lymphatic thrombosis and dysfunction caused by cigarette smoke exposure precedes emphysema in mice.
Scientific reports.
2022
Academic Article
GET IT
Times cited: 2 -
Evaluation of Albumin Kinetics in Critically Ill Patients With Coronavirus Disease 2019 Compared to Those With Sepsis-Induced Acute Respiratory Distress Syndrome.
Critical care explorations.
2021
Academic Article
GET IT
Times cited: 3 - The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues. American journal of respiratory and critical care medicine. 2021 Editorial Article GET IT
-
Reversal of emphysema by restoration of pulmonary endothelial cells.
The Journal of experimental medicine.
2021
Academic Article
GET IT
Times cited: 20 -
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
2020
GET IT
Times cited: 85 -
Autophagy in chronic lung disease.
2020
GET IT
Times cited: 1 - Manmade Macrophage Offers a New Therapy for Pulmonary Alveolar Proteinosis. American journal of respiratory and critical care medicine. 2018 Editorial Article GET IT
-
Autophagy and inflammation in chronic respiratory disease.
Autophagy.
2018
Review
GET IT
Times cited: 254 -
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Leukemia & lymphoma.
2014
Academic Article
GET IT
Times cited: 27 -
Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
Cancer research.
2010
Academic Article
GET IT
Times cited: 79 -
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Cancer research.
2009
Academic Article
GET IT
Times cited: 125 -
A mouse gene that coordinates epigenetic controls and transcriptional interference to achieve tissue-specific expression.
Molecular and cellular biology.
2007
Academic Article
GET IT
Times cited: 9